Serenex

About:

Serenex is a drug discovery and development company focused on oncology.

Top Investors: Eli Lilly, Seagate Technology, Western Technology Investment, Intersouth Partners, Seaflower Ventures

Description:

Serenex is a medical drug discovery and development company that focuses on oncology. The company develops Hsp90 product platform that provides a collection of small molecule Hsp90 inhibitors for cancer, inflammatory diseases, fungal infection resistance, viral diseases, and neurodegenerative diseases, such as Alzheimer's. It also develops SNX-1012, a product for oral mucositis in solid tumor patients. Serenex is a U.S.-based company that was founded in 2000 and it was acquired in 2008 by Pfizer.

Total Funding Amount:

$81M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2000-01-01

Founders:

Lawrence G. Miller

Number of Employees:

11-50

Last Funding Date:

2007-06-28

IPO Status:

Private

Industries: